Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Wood

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate CancerAndrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Nature Communications|December 4, 2015
Target engagement and drug residence time can be observed in living cells with BRETMatthew B Robers, Melanie L Dart, Carolyn C Woodroofe, et al.
ACS Chemical Biology|June 7, 2008
HaloTag: a novel protein labeling technology for cell imaging and protein analysisGeorgyi V Los, Lance P Encell, Mark G McDougall, et al.
ACS Chemical Biology|August 17, 2012
Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrateMary P Hall, James Unch, Brock F Binkowski, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Plos One|June 19, 2013
Imaging proteolytic activity in live cells and animal modelsStefanie Galbán, Yong Hyun Jeon, Brittany M Bowman, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 12, 2021
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UKK Banfill, W Croxford, I Fornacon-Wood, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate CancerAndrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Nature Communications|December 4, 2015
Target engagement and drug residence time can be observed in living cells with BRETMatthew B Robers, Melanie L Dart, Carolyn C Woodroofe, et al.
ACS Chemical Biology|June 7, 2008
HaloTag: a novel protein labeling technology for cell imaging and protein analysisGeorgyi V Los, Lance P Encell, Mark G McDougall, et al.
ACS Chemical Biology|August 17, 2012
Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrateMary P Hall, James Unch, Brock F Binkowski, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Plos One|June 19, 2013
Imaging proteolytic activity in live cells and animal modelsStefanie Galbán, Yong Hyun Jeon, Brittany M Bowman, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 12, 2021
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UKK Banfill, W Croxford, I Fornacon-Wood, et al.
Pageof 29